TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36577981

Group type: EXPERIMENTAL
Intervention: Neonates with HIE (study group)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Neonates with HIE (severe group)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Neonates with HIE (mild group)
Number of subjects: 90
Study: 34530839

Group type: EXPERIMENTAL
Intervention: Robotic driver assistance module of powered wheelchair (PWC)
Number of subjects: 23

Group type: COMPARATOR
Intervention: No assistance (control)
Number of subjects: 23
Study: 33756097

Group type: EXPERIMENTAL
Intervention: Jaw exercise (JE) intervention program combined with an information/counselling program (IC)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Information/counselling alone (IC)
Number of subjects: 83
Study: 32409277

Group type: EXPERIMENTAL
Intervention: Congenital Adrenal Hyperplasia (CAH)
Number of subjects: 1628

Group type: EXPERIMENTAL
Intervention: Mixed Gonadal Dysgenesis (MGD)
Number of subjects: 1628

Group type: EXPERIMENTAL
Intervention: Partial Androgen Insensitivity Syndrome (PAIS)
Number of subjects: 1628

Group type: EXPERIMENTAL
Intervention: Overall utility value
Number of subjects: 1628

Group type: EXPERIMENTAL
Intervention: Gender identity concerns
Number of subjects: 1628

Group type: EXPERIMENTAL
Intervention: Urinary function concerns
Number of subjects: 1628

Group type: EXPERIMENTAL
Intervention: Surgical complications concerns
Number of subjects: 1628

Group type: EXPERIMENTAL
Intervention: Support for early surgical intervention
Number of subjects: 1628

Group type: EXPERIMENTAL
Intervention: Support for delayed surgical intervention
Number of subjects: 1628
Study: 35869616

Group type: EXPERIMENTAL
Intervention: 3-day aspirin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0-day aspirin + 3-day clopidogrel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3-day aspirin + 7-day clopidogrel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0-day aspirin + 7-day clopidogrel
Number of subjects: 0
Study: 33990843

Group type: EXPERIMENTAL
Intervention: E‐cigarettes shown on Instagram
Number of subjects: 928
Study: 32295718

Group type: EXPERIMENTAL
Intervention: High dose influenza vaccine (HD) - Sanofi Pasteur Fluzone High Dose [60 mcg × 3 strains]
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard dose influenza vaccine (SD) - Sanofi Pasteur Fluzone® [15 mcg × 3 strains]
Number of subjects: 0
Study: 36141714

Group type: EXPERIMENTAL
Intervention: Mindfulness training program
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group (no mindfulness training)
Number of subjects: 74
Study: 34036644

Group type: EXPERIMENTAL
Intervention: Plasma-MAC
Number of subjects: 36

Group type: COMPARATOR
Intervention: MAC
Number of subjects: 36

Group type: COMPARATOR
Intervention: UTM
Number of subjects: 36

Group type: COMPARATOR
Intervention: Plasma-UTM
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Plasma-abutments
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 36
Study: 34145518

Group type: EXPERIMENTAL
Intervention: Relational Agent + TAU
Number of subjects: 178

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 178
Study: 34410635

Group type: EXPERIMENTAL
Intervention: KdD
Number of subjects: 66

Group type: COMPARATOR
Intervention: Kd
Number of subjects: 66
Study: 35183448

Group type: EXPERIMENTAL
Intervention: Intravenous patient-controlled analgesia (IV-PCA)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Patient-controlled epidural analgesia (PCEA)
Number of subjects: 110
Study: 33096271

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Pregabalin and Placebo (combined analysis)
Number of subjects: 43
Study: 32030573

Group type: EXPERIMENTAL
Intervention: Nicosulfuron at 6 g a.e. ha‐1
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Nicosulfuron at 12 g a.e. ha‐1
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Nicosulfuron at 24 g a.e. ha‐1
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Nicosulfuron at 48 g a.e. ha‐1
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Nicosulfuron at 60 g a.e. ha‐1
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control (0 g a.e. ha‐1)
Number of subjects: 5
Study: 36108923

Group type: EXPERIMENTAL
Intervention: Abrocitinib 200 mg once daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Abrocitinib 100 mg once daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg every 2 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34787246

Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine digluconate (CHX)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (without pre-treatment)
Number of subjects: 48
Study: 32039716

Group type: EXPERIMENTAL
Intervention: High HIV-related stigma (score ≥ 27)
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: High MSM-related stigma (score ≥ 6)
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Any IPV
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Physical IPV
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Psychological IPV
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Sexual IPV
Number of subjects: 367
Study: 35933942

Group type: EXPERIMENTAL
Intervention: Extended-release injectable naltrexone (XR-NTX) before release
Number of subjects: 86

Group type: COMPARATOR
Intervention: Extended-release injectable naltrexone (XR-NTX) referral after release
Number of subjects: 86
Study: 34477015

Group type: EXPERIMENTAL
Intervention: Identifying signs
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Informative signs
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Architectural features
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Four types of signage (identifying signs, informative signs, directional, and safety/regulatory signs)
Number of subjects: 24
Study: 32971192

Group type: EXPERIMENTAL
Intervention: Newly created AVFs in Japan
Number of subjects: 2040

Group type: COMPARATOR
Intervention: Newly created AVFs in EUR/ANZ and US
Number of subjects: 2040

Group type: EXPERIMENTAL
Intervention: Not using an arteriovenous access within 6 months of AVF creation
Number of subjects: 2040
Study: 33158101

Group type: EXPERIMENTAL
Intervention: DAGIS intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0

Group type: COMPARATOR
Intervention: High PEL control group
Number of subjects: 0
Study: 34783956

Group type: EXPERIMENTAL
Intervention: Pharmaceutical care together with use of the PROMPT‐QoL
Number of subjects: 286

Group type: COMPARATOR
Intervention: Pharmaceutical care only
Number of subjects: 286
Study: 33277746

Group type: EXPERIMENTAL
Intervention: CsA/MPA
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: EVL/MPA/steroids
Number of subjects: 151
Study: 34627499

Group type: EXPERIMENTAL
Intervention: Antimicrobial stewardship intervention (education, engaging opinion leaders, prospective audit and feedback of antibiotic use)
Number of subjects: 4084

Group type: COMPARATOR
Intervention: Control period (broad-spectrum antibiotics)
Number of subjects: 4084

Group type: EXPERIMENTAL
Intervention: Intervention period (antibiotic stewardship)
Number of subjects: 4084
Study: 34481407

Group type: EXPERIMENTAL
Intervention: CyclASol 0.1%
Number of subjects: 328

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 328
Study: 35555211

Group type: EXPERIMENTAL
Intervention: Early Follicular (EF) phase
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Late Follicular (LF) phase
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Mid-Luteal (ML) phase
Number of subjects: 8
Study: 33069259

Group type: EXPERIMENTAL
Intervention: Nomograms for predicting overall survival (OS)
Number of subjects: 1541

Group type: EXPERIMENTAL
Intervention: Nomograms for predicting cancer-specific survival (CSS)
Number of subjects: 1541

Group type: COMPARATOR
Intervention: Nomograms compared to AJCC staging system
Number of subjects: 1541
Study: 36481522

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate and nicardipine (combination therapy)
Number of subjects: 1523

Group type: COMPARATOR
Intervention: Isosorbide dinitrate alone (control)
Number of subjects: 1523
Study: 34836856

Group type: EXPERIMENTAL
Intervention: Nebivolol 5-10mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Atenolol 25-50mg
Number of subjects: 0
Study: 36371234

Group type: EXPERIMENTAL
Intervention: Belimumab and rituximab combined with standard of care (prednisolone and mycophenolate)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard of care (prednisolone and mycophenolate)
Number of subjects: 70
Study: 34034418

Group type: EXPERIMENTAL
Intervention: Mifepristone 10 mg/day
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study: 36127081

Group type: EXPERIMENTAL
Intervention: Ecological Momentary Intervention called SmartSafe in addition to treatment as usual (TAU)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual (TAU) with monitoring using Ecological Momentary Assessment (EMA)
Number of subjects: 0
Study: 34607597

Group type: EXPERIMENTAL
Intervention: Free gingival graft (FGG) before implant placement
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (without FGG before implant placement)
Number of subjects: 26
Study: 32842983

Group type: EXPERIMENTAL
Intervention: Broad-spectrum multinutrient formula for 12 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Active control formula containing iodine and riboflavin for 12 weeks
Number of subjects: 120
Study: 36138381

Group type: EXPERIMENTAL
Intervention: Nocebo education (n=49)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Attention control (n=51)
Number of subjects: 100
Study: 33197414

Group type: EXPERIMENTAL
Intervention: 800 mg IV ibuprofen
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (100 mL saline)
Number of subjects: 40
Study: 35777250

Group type: EXPERIMENTAL
Intervention: Heart Rate Variability (HRV) biofeedback treatment including at-home breathing practice
Number of subjects: 21

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 21
Study: 32144896

Group type: EXPERIMENTAL
Intervention: Dietary weight loss (D) + Exercise (E)
Number of subjects: 343

Group type: COMPARATOR
Intervention: Dietary weight loss (D)
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Multiple outcome random forest model
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: List-based models
Number of subjects: 343
Study: 33263669

Group type: EXPERIMENTAL
Intervention: HF 20s + silanization
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: HF 60s + silanization
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: HF 120s + silanization
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: HF 120s + SBU
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: HF 120s
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: MEP
Number of subjects: 120

Group type: COMPARATOR
Intervention: HF 20s + SBU
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: HF 20s
Number of subjects: 120
Study: 35524833

Group type: EXPERIMENTAL
Intervention: Intradialytic exercise (30 min of aerobic exercise using a cycle ergometer and resistance training with elastic tube, three times per week for 1 year)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Intradialytic exercise
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 46
Study: 34757341

Group type: EXPERIMENTAL
Intervention: Active tDCS (n=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham tDCS (n=20)
Number of subjects: 40
Study: 32235518

Group type: EXPERIMENTAL
Intervention: Ketogenic low-carbohydrate high-fat (LCHF) diet
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control diet (National Food Agency recommended diet)
Number of subjects: 24
Study: 34407033

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Baseline pain variability (coefficient of variation, SD, difference between highest and lowest NRS score)
Number of subjects: 160
Study: 34165508

Group type: EXPERIMENTAL
Intervention: 5 years of zoledronate treatment (4 mg intravenously every 3 months for 2 years, followed by 4 mg intravenously every 6 months for 3 years)
Number of subjects: 3754

Group type: COMPARATOR
Intervention: 2 years of zoledronate treatment (4 mg intravenously every 3 months for 2 years)
Number of subjects: 3754

Group type: EXPERIMENTAL
Intervention: 5 years of zoledronate treatment
Number of subjects: 3754

Group type: COMPARATOR
Intervention: 2 years of zoledronate treatment
Number of subjects: 3754
Study: 33272042

Group type: EXPERIMENTAL
Intervention: Kaempferia parviflora extract (360 mg/day)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 194
Study: 34560841

Group type: EXPERIMENTAL
Intervention: LF‐rTMS+cTBS group (n=30)
Number of subjects: 90

Group type: COMPARATOR
Intervention: LF‐rTMS group (n=30)
Number of subjects: 90

Group type: COMPARATOR
Intervention: cTBS group (n=30)
Number of subjects: 90
Study: 32740578

Group type: EXPERIMENTAL
Intervention: Abdominoplasty with preservation of Scarpa fascia (group B)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Classic full abdominoplasty (group A)
Number of subjects: 160
Study: 34181888

Group type: EXPERIMENTAL
Intervention: Hydrotherapy
Number of subjects: 44

Group type: COMPARATOR
Intervention: Tactile-kinesthetic stimulation
Number of subjects: 44
Study: 33915150

Group type: EXPERIMENTAL
Intervention: Revision surgery
Number of subjects: 3717

Group type: EXPERIMENTAL
Intervention: Longer thrombin time (TT)
Number of subjects: 3717

Group type: EXPERIMENTAL
Intervention: Using more than one gelatin sponge or using styptic powder in the surgery
Number of subjects: 3717

Group type: COMPARATOR
Intervention: Control group (patients without reoperations)
Number of subjects: 3717
Study: 34016612

Group type: EXPERIMENTAL
Intervention: Cotadutide 100 μg
Number of subjects: 834

Group type: EXPERIMENTAL
Intervention: Cotadutide 200 μg
Number of subjects: 834

Group type: EXPERIMENTAL
Intervention: Cotadutide 300 μg
Number of subjects: 834

Group type: EXPERIMENTAL
Intervention: Liraglutide 1.8 mg
Number of subjects: 834

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 834
Study: 33264337

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) 400 mg twice for 1 day or HCQ 200 mg twice daily for 6 days
Number of subjects: 33

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 33
Study: 36229051

Group type: EXPERIMENTAL
Intervention: Adaptive servo-ventilation (ASV)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Guideline-based heart failure treatment alone (Control)
Number of subjects: 40
Study: 34454875

Group type: EXPERIMENTAL
Intervention: Ischemic cardiomyopathy (ICM)
Number of subjects: 4803

Group type: COMPARATOR
Intervention: Nonischemic cardiomyopathy (NICM)
Number of subjects: 4803
Study: 32342101

Group type: EXPERIMENTAL
Intervention: Anodal tDCS on the prefrontal cortex
Number of subjects: 124

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 124
Study: 32152503

Group type: EXPERIMENTAL
Intervention: Pembrolizumab 200 mg I.V. every 3 weeks
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 29
Study: 33626326

Group type: EXPERIMENTAL
Intervention: Topical Oxygen Jet Therapy (TOJT)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 73
Study: 35851027

Group type: EXPERIMENTAL
Intervention: Enhanced case detection using LAMP technology, microscopy, and rapid diagnostic test for malaria at each antenatal care visit
Number of subjects: 2583

Group type: COMPARATOR
Intervention: Standard of care (venous blood sample for malaria diagnosis only in symptomatic patients)
Number of subjects: 2583
Study: 33719833

Group type: EXPERIMENTAL
Intervention: 7 + 3 induction
Number of subjects: 1247
Study: 36124112

Group type: EXPERIMENTAL
Intervention: Topical sesame oil
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo oil
Number of subjects: 120
Study: 32359042

Group type: EXPERIMENTAL
Intervention: eCHECKUP TO GO intervention
Number of subjects: 311

Group type: COMPARATOR
Intervention: Assessment-only control group
Number of subjects: 311
Study: 36235739

Group type: EXPERIMENTAL
Intervention: Intervention Group (school-based and home-based interventions to reduce SSB consumption)
Number of subjects: 1633

Group type: COMPARATOR
Intervention: Control Group (no interventions)
Number of subjects: 1633

Group type: EXPERIMENTAL
Intervention: Intervention Group (among participants whose parents’ educational attainment was above 9 years)
Number of subjects: 1633

Group type: COMPARATOR
Intervention: Control Group (among participants whose parents’ educational attainment was above 9 years)
Number of subjects: 1633

Group type: EXPERIMENTAL
Intervention: Level-Down (reduced SSB consumption)
Number of subjects: 1633
Study: 33662054

Group type: EXPERIMENTAL
Intervention: Manual cleaning
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Machine-aided cleaning
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Combination of manual and machine-aided cleaning
Number of subjects: 32

Group type: COMPARATOR
Intervention: No cleaning
Number of subjects: 32
Study: 32444457

Group type: EXPERIMENTAL
Intervention: Linagliptin
Number of subjects: 6979

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6979
Study: 33933152

Group type: EXPERIMENTAL
Intervention: 6 weeks of CMC1 joint distraction
Number of subjects: 52

Group type: COMPARATOR
Intervention: 8 weeks of CMC1 joint distraction
Number of subjects: 52
Study: 35102749

Group type: EXPERIMENTAL
Intervention: Belt electrode skeletal muscle electrical stimulation (B-SES) combined with conventional physical therapy for 20 minutes each
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional physical therapy for 20 minutes
Number of subjects: 32
Study: 33888413

Group type: EXPERIMENTAL
Intervention: Fully automated multihormone artificial pancreas
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Modified multihormone algorithm
Number of subjects: 9

Group type: COMPARATOR
Intervention: Insulin‐alone artificial pancreas
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Final dual-hormone system (insulin and pramlintide)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Multihormone arm
Number of subjects: 9

Group type: COMPARATOR
Intervention: Insulin‐alone arm
Number of subjects: 9
Study: 35837984

Group type: EXPERIMENTAL
Intervention: CamAPS FX closed loop system
Number of subjects: 98

Group type: COMPARATOR
Intervention: Closed loop (CL) system
Number of subjects: 98

Group type: COMPARATOR
Intervention: Insulin pump (with or without CGM)
Number of subjects: 98
Study: 34344583

Group type: EXPERIMENTAL
Intervention: Ureteral access sheath (UAS) insertion (Group B)
Number of subjects: 181

Group type: COMPARATOR
Intervention: No UAS insertion (Group A)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: UAS insertion (Group B)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Overall stone-free rate
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Clinically insignificant residual fragments
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Final stone-free rate
Number of subjects: 181
Study: 32135648

Group type: EXPERIMENTAL
Intervention: Chrono-chemotherapy combined with intensity modulated radiotherapy (IMRT)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Conventional chemotherapy combined with intensity modulated radiotherapy (IMRT)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Chrono-chemotherapy combined with IMRT
Number of subjects: 160

Group type: COMPARATOR
Intervention: Conventional chemotherapy combined with IMRT
Number of subjects: 160
Study: 33815657

Group type: EXPERIMENTAL
Intervention: L-Arginine (5 grams per day)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 34082142

Group type: EXPERIMENTAL
Intervention: Fresh pomegranate juice (250 mL twice daily for 2 weeks)
Number of subjects: 26
Study: 33143831

Group type: EXPERIMENTAL
Intervention: Sectra visualisation table (SVT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Traditional lecture (TRAD)
Number of subjects: 50
Study: 35192801

Group type: EXPERIMENTAL
Intervention: Virtual personal training (VIRT) using bodyweight resistance exercises for 3 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Traditional supervised strength training (STUD) in a strength training studio for 3 weeks
Number of subjects: 20
Study: 34831554

Group type: EXPERIMENTAL
Intervention: AET + ISP (40 g/day, 5 days a week for 8 weeks)
Number of subjects: 16

Group type: COMPARATOR
Intervention: AET
Number of subjects: 16
Study: 35656573

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery (LAP)
Number of subjects: 8410

Group type: COMPARATOR
Intervention: Open surgery (OPEN)
Number of subjects: 8410
Study: 34501299

Group type: EXPERIMENTAL
Intervention: Dry needling
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (no dry needling)
Number of subjects: 50
Study: 32532339

Group type: EXPERIMENTAL
Intervention: Non-Maasai adolescents
Number of subjects: 906

Group type: EXPERIMENTAL
Intervention: Maasai adolescents
Number of subjects: 906

Group type: COMPARATOR
Intervention: Adolescents from Longido district
Number of subjects: 906

Group type: COMPARATOR
Intervention: Adolescents with good oral hygiene
Number of subjects: 906

Group type: EXPERIMENTAL
Intervention: Non-Maasai adolescents with DMFT > 0
Number of subjects: 906

Group type: EXPERIMENTAL
Intervention: Non-Maasai adolescents with 2Q/TMD > 0
Number of subjects: 906

Group type: EXPERIMENTAL
Intervention: Maasai adolescents with DMFT > 0
Number of subjects: 906

Group type: EXPERIMENTAL
Intervention: Maasai adolescents with 2Q/TMD > 0
Number of subjects: 906
Study: 34523303

Group type: EXPERIMENTAL
Intervention: 400 mg vaginal progesterone
Number of subjects: 100

Group type: COMPARATOR
Intervention: 200 mg vaginal progesterone
Number of subjects: 100
Study: 32013277

Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg bolus followed by 0.12 mg/kg/h continuous infusion)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 184
Study: 36481539

Group type: EXPERIMENTAL
Intervention: Hands-On Training Program (HTP)
Number of subjects: 167
Study: 35266869

Group type: EXPERIMENTAL
Intervention: Internet group (self-completing questionnaires via a dedicated website)
Number of subjects: 840

Group type: COMPARATOR
Intervention: Telephone group (questionnaires administered during a telephone interview)
Number of subjects: 840

Group type: COMPARATOR
Intervention: Matched sample from internet and telephone groups (1:1 ratio)
Number of subjects: 840